Magle Biopharma AB

ABActive

Org 5566560156Sheelevägen 2, 223 63 LundResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2004 · 22 years old1-4 employees

Overview Financials People & ownership Related companies

Magle Biopharma AB is a Swedish AB based in Lund, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2004, the company reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

Net profit 2024

SEK 2K

+3% vs 2023

Key ratios

See full ratios →

2.0%

This company

20202024

0.5×

This company

20202024

0.0%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -4,6M	—
Net profit	SEK 2K	+3%
Total assets	SEK 46,2M	+4900%
Equity	SEK 927K	0%
Employees	—	—

Contact

Address

Sheelevägen 2, 223 63 Lund

Phone

+4646157754

info@maglechemoswed.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Magle Biopharma AB?

Magle Biopharma AB is registered with Bolagsverket / SCB under Org 5566560156.

Who is the chairman of Magle Biopharma AB?

Stig Løkke Pedersen chairs the board of Magle Biopharma AB, in role since 2026.

Where is Magle Biopharma AB headquartered?

Magle Biopharma AB's registered address is Sheelevägen 2.

Magle Biopharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Magle Biopharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Magle Biopharma AB